No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 667,892 | 613,889 | 655,265 | 494,738 | 468,237 | 486,802 | 462,343 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 22,976 | 22,936 | 24,500 | -7,034 | 28,981 | -4,816 | 23,872 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Established in 1897 and headquartered in Tokyo, Japan, UBE Corporation, formerly known as Ube Industries, Ltd., is a globally diversified enterprise with core operations spanning chemicals, construction materials, and machinery. The company maintains a substantial international footprint, serving markets across Japan, North America, Europe, Africa, the Middle East, Thailand, India, Latin America, and other global regions. UBE's extensive chemicals division provides a wide range of products including synthetic rubber, engineering plastics, polyimide, polyethylene, caprolactam, nylon, plastic films, polypropylene molded products, fibers, fiber-reinforced plastics, industrial chemicals, liquefied gases, ammonium sulfate, battery components, separation membranes, fine chemicals, ceramics, high-purity chemicals, semiconductor gas products, and materials for polyurethane resins. Additionally, the company offers specialized chemical services such as contract manufacturing for active pharmaceutical ingredients (APIs) and intermediates, supplies aromatic SF5 compounds, markets FLUOLEAD (a novel nucleophilic fluorinating agent), and supports drug discovery and pipeline development initiatives. Within the construction materials segment, UBE supplies essential products like cement, ready-mixed concrete, soil stabilizing cement, general building materials, limestone, calcia, magnesia, and other specialty inorganic compounds. This division also actively engages in resource recycling and the distribution of coal. The machinery segment focuses on the production and supply of die-casting and injection molding machines, extrusion presses, UBE vertical mills, kilns, furnaces, dryers, water screening equipment, storage and transportation systems, bridges, steel structures, along with steel billets, cast iron, and various other steel products. Beyond these core areas, UBE Corporation is also involved in the generation and supply of electric power.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Established in 1897 and headquartered in Tokyo, Japan, UBE Corporation, formerly known as Ube Industries, Ltd., is a globally diversified enterprise with core operations spanning chemicals, construction materials, and machinery. The company maintains a substantial international footprint, serving markets across Japan, North America, Europe, Africa, the Middle East, Thailand, India, Latin America, and other global regions. UBE's extensive chemicals division provides a wide range of products including synthetic rubber, engineering plastics, polyimide, polyethylene, caprolactam, nylon, plastic films, polypropylene molded products, fibers, fiber-reinforced plastics, industrial chemicals, liquefied gases, ammonium sulfate, battery components, separation membranes, fine chemicals, ceramics, high-purity chemicals, semiconductor gas products, and materials for polyurethane resins. Additionally, the company offers specialized chemical services such as contract manufacturing for active pharmaceutical ingredients (APIs) and intermediates, supplies aromatic SF5 compounds, markets FLUOLEAD (a novel nucleophilic fluorinating agent), and supports drug discovery and pipeline development initiatives. Within the construction materials segment, UBE supplies essential products like cement, ready-mixed concrete, soil stabilizing cement, general building materials, limestone, calcia, magnesia, and other specialty inorganic compounds. This division also actively engages in resource recycling and the distribution of coal. The machinery segment focuses on the production and supply of die-casting and injection molding machines, extrusion presses, UBE vertical mills, kilns, furnaces, dryers, water screening equipment, storage and transportation systems, bridges, steel structures, along with steel billets, cast iron, and various other steel products. Beyond these core areas, UBE Corporation is also involved in the generation and supply of electric power.
